PFPT
BMY.RT

Pinnacle Financial Partners (Tennessee)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,751
Closed -$4K – 475
2020
Q4 		$4K Hold
1,751
– – ﹤0.01% 430
2020
Q3 		$4K Hold
1,751
– – ﹤0.01% 423
2020
Q2 		$6K Buy
+1,751
New +$6.32K ﹤0.01% 402
2020
Q1 		– Sell
-1,751
Closed -$5K – 489
2019
Q4 		$5K Buy
+1,751
New +$4.55K ﹤0.01% 442

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s BMY.RT Position: Q1 2021 in Review

Pinnacle Financial Partners (Tennessee) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,751 shares — an estimated $4K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $6K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 1,751 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $4K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $6K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q1 2021, filed 19 Apr 2021.